Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
|
10.09.2025 00:36:01
|
Eli Lilly Launches Global "Brain Health Matters" Campaign With Julianne Moore
(RTTNews) - Eli Lilly and Company (LLY) has launched Brain Health Matters, a global initiative encouraging proactive steps to support brain health and reduce dementia risk, including Alzheimer's disease.
The multi-year campaign builds on 35 years of Lilly's research and aims to make brain health a regular part of long-term wellness planning.
Actress and advocate Julianne Moore has partnered with Lilly in the U.S. to raise awareness, particularly among women, who represent nearly two-thirds of Alzheimer's cases.
Drawing from her role in Still Alice and her advocacy work, Moore will encourage individuals to discuss dementia risk, annual cognitive assessments, and lifelong brain health habits with their doctors.
Lilly Neuroscience president Anne E. White said early and regular assessments are critical as Alzheimer's can begin decades before symptoms appear. She emphasized that open conversations can help reduce stigma and allow people to take meaningful action sooner.
Moore added that proactive care is key to preserving independence and the ability to enjoy meaningful activities, urging people to prioritize brain health.
Launched during World Alzheimer's Month, the campaign offers educational resources, tools for building cognitive health plans, and guidance on lifestyle changes. It will run on U.S. television, digital, and audio platforms, alongside events, social media content, and an informational website, with plans for global expansion.
Tuesday LLY closed at $750.61, up 1.62%, and traded after hours at $747.50, down 0.41%, on the NYSE.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
|
03.12.25 |
Eli Lilly not yet ready to unfreeze UK investments, says pharma boss (Financial Times) | |
|
02.12.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Eli Lilly-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
|
28.11.25 |
Freundlicher Handel: S&P 500 zum Handelsende mit Zuschlägen (finanzen.at) | |
|
28.11.25 |
S&P 500-Handel aktuell: S&P 500 steigt nachmittags (finanzen.at) | |
|
28.11.25 |
Freitagshandel in New York: S&P 500 am Mittag freundlich (finanzen.at) | |
|
28.11.25 |
Aufschläge in New York: S&P 500 zum Start mit Zuschlägen (finanzen.at) | |
|
25.11.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Investment in Eli Lilly von vor 5 Jahren abgeworfen (finanzen.at) | |
|
21.11.25 |
Eli Lilly-Aktie im Höhenflug: Billionen-Grenze überschritten dank starker Wachstumsziele (dpa-AFX) |
Analysen zu Eli Lillymehr Analysen
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
| Eli Lilly | 873,40 | 0,58% |
|